Teledyne increases stake in Optech
Military-industrial conglomerate Teledyne Technologies said April 3 that its Dalsa subsidiary has increased its ownership stake in the parent company of Optech from 19 percent to 51 percent. Terms of the deal were not disclosed. Optech is a Canadian maker of laser-based survey and digital imaging equipment. Thousand Oaks-based Teledyne has been moving away from Read More →
Read More →Amgen, AstraZeneca strike drug development deal
Amgen has entered a development deal with London-based AstraZeneca to jointly commercialize five anti-inflammation drugs. Under the terms of the agreement announced April 2, AstraZeneca will pay a one-time $50 million payment to Amgen and will be responsible for helping the Thousand Oaks-based biotech giant commercialize its inflammation drug pipeline. The firms said in a Read More →
Read More →Sientra funding rises to $151M
Sientra, the Santa Barbara breast implant company that recently received the first FDA approval in several decades for new implants for the U.S. market, has closed a $65 million funding round, bringing its total capital raised to $151 million. The lead investor on the private equity deal was London-based life sciences fund Abingworth. Sientra’s existing Read More →
Read More →Bill Gates: New nuclear could be “energy miracle”
Microsoft founder Bill Gates is placing his chips on nuclear technology these days.
Read More →
A new player in Silicone Alley: Sientra enters breast implant industry
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →
Sponsored content:
2015-2016 Giving Guide
